๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The clinical observation of combined chemotherapy of irinotecan and cisplatin in the treatment of relapsed advanced small cell lung cancer

โœ Scribed by Zhonghai Ren; Chenghui Zhang; Ming Li

Publisher
Springer
Year
2008
Tongue
English
Weight
504 KB
Volume
7
Category
Article
ISSN
1610-1979

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combination chemotherapy with mitomycin-
Combination chemotherapy with mitomycin-C, cisplatin, and vinblastine in the treatment of non-small-cell lung cancer
โœ Niell, Harvey B. ;Griffin, John P. ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 443 KB

The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit

Combination chemotherapy with cisplatin
Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer
โœ F. Figoli; A. Veronesi; M. G. Trovo; D. Errante; M. Della Valentina; V. Zagonel; ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 447 KB

A total of 52 consecutive, previously untreated patients with small-cell lung cancer (SCLC) were scheduled to receive six cycles of a combination of etoposide (75 mg/m2 per day) and cisplatin (20 mg/m2 per day), each cycle given over 5 consecutive days. In all, 28 patients had extensive disease (ED)